PhD defence J.X. (Xavier) Harmeling

Optimising Outcomes in Breast Reconstruction

On Wednesday 9 December 2026 J.X. Harmeling will defend the doctoral thesis titled: Optimising Outcomes in Breast Reconstruction

Promotor
Prof.dr. M.A.M. Mureau
Co-promotor
Dr. E.M.L. Corten
Date
Wednesday 9 Dec 2026, 13:00 - 14:30
Type
PhD defence
Space
Professor Andries Querido Hall
Building
Education Centre
Location
Erasmus MC
Add to calendar

Below is a brief summary of the dissertation:

Around one in seven women develops breast cancer, and many of them undergo a mastectomy. Breast reconstruction, usually with a breast implant, can considerably improve quality of life afterwards. This thesis aimed to improve the quality of breast reconstruction care by strengthening the evidence behind clinical choices.

Interviews and a survey among plastic surgeons showed that the choice of implant is based not only on research findings, but also on brand reputation, cost and availability. Using data from the Dutch Breast Implant Registry, we compared almost 4000 implants with a smooth, textured or polyurethane-covered surface. Surface type had no clear effect on the overall chance of revision surgery, although polyurethane-covered implants were more often replaced because of hardening of the breast or asymmetry. In the TIPI Trial, the first study in which patients were randomly assigned to either a textured or a polyurethane-covered implant, we found no difference in short-term complications or reoperations. Long-term results will follow. We also developed a website where patients can look up reliable safety information about their own implant using its serial number. It was visited most after negative media coverage.

Finally, we studied the interplay between reconstruction and cancer treatment. Women previously treated with chest radiotherapy for Hodgkin lymphoma did not have a higher risk of reoperation or failure of the reconstruction. Moreover, reconstruction during the same operation as the mastectomy does not delay the start of chemotherapy to a clinically relevant extent.

These findings support better-informed decisions by doctors and patients alike.

More information

The public defence will start exactly at 13.00 hrs. The doors will be closed once the public defence starts, latecomers can access the hall via the fourth floor. Given the solemn nature of the meeting, we advise not to bring children under the age of 6 to the first part of the ceremony.
A livestream link has been provided to candidate.

Compare 0 study programme